Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label, Single Arm Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Type II Diabetic Patients With Hypertension

NCT00403481 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00403481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label, Single Arm Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Type II Diabetic Patients With Hypertension
Lead sponsor
Daiichi Sankyo
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2006
Completion date
December 31, 2007
Enrollment
192 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension